OncoConsult

Industry / private company


Location: Hamburg, Germany (DE) DE

ISNI: -


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Return of individual genomic research results within the PRAEGNANT multicenter registry study (2022) Hübner H, Rübner M, Kurbacher C, Hadji P, Hartkopf AD, Lux MP, Huober J, et al. Journal article Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status (2021) Hein A, Hartkopf AD, Emons J, Lux MP, Volz B, Taran FA, Overkamp F, et al. Journal article Update Breast Cancer 2020 Part 5 - Moving Therapies from Advanced to Early Breast Cancer Patients (2021) Lux MP, Schneeweiss A, Hartkopf AD, Müller V, Janni W, Belleville E, Stickeler E, et al. Journal article, Review article Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer (2021) Lüftner D, Hartkopf AD, Lux MP, Overkamp F, Tesch H, Titzmann A, Pöschke P, et al. Journal article, Review article Update Breast Cancer 2020 Part 3 - Early Breast Cancer (2020) Huober J, Schneeweiss A, Hartkopf AD, Müller V, Lux MP, Janni W, Ettl J, et al. Journal article, Review article Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer (2020) Tesch H, Müller V, Wöckel A, Ettl J, Belleville E, Schütz F, Hartkopf A, et al. Journal article, Review article Use of a molecular Registry (PRAEGNANT) for Patient-Selection and Biomarker-Analysis for the SHERBOC Study (2020) Hübner H, Kurbacher C, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Conference contribution Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion Diagnostics (2020) Lüftner D, Schneeweiss A, Hartkopf AD, Müller V, Wöckel A, Janni W, Ettl J, et al. Journal article Klinische Endpunkte in Real-World-Register-Studien (2020) Hartkopf AD, Emons J, Lux MP, Taran FA, Overkamp F, Tesch H, Titzmann A, et al. Journal article, Review article
1 2 3